US Pharma MarketingThe post FDA approves Stryker’s Sonopet 3 surgical platform appeared first on Medical Device Network.
FDA approves Stryker’s Sonopet 3 surgical platform
The US FDA has granted 510(k) clearance to Stryker for Sonopet 3, the medical technology company's latest ultrasonic platform for bone and soft tissue removal. Sonopet 3 is scheduled to be used in its first clinical cases, ahead of an anticipated commercial rollout. The platform incorporates several technological additions designed to assist integration across clinical settings. Credit: Stryker. The US Food and Drug Administration (FDA) has granted 510(k) clearance to Stryker for Sonopet 3, the medical technology company’s latest ultrasonic platform for bone and soft tissue removal. Following the regulatory decision, the device is scheduled for use in its first…
The US FDA has granted 510(k) clearance to Stryker for Sonopet 3, the medical technology company's latest ultrasonic platform for bone and soft tissue removal.
Source: Medical Device Network